Robuta

https://www.rush.edu/clinical-trials/pediatric-vitiligo-study-ruxolitinib-cream-phase-3-trial Pediatric Vitiligo Study: Ruxolitinib Cream Phase 3 Trial | Rush This Phase 3 study is testing a cream called ruxolitinib in children ages 2 to under 12 who have nonsegmental vitiligo, a skin condition that causes white... phase 3 trialpediatricvitiligostudyruxolitinib https://www.jnj.com/media-center/press-releases/nipocalimab-pivotal-phase-3-trial-demonstrates-longest-sustained-disease-control-in-fcrn-class Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class Jun 28, 2024 - First-and-only FcRn blocker to demonstrate superiority in activities of daily living (MG-ADLa) over placebo when added to standard of care over 24 weeks in... phase 3 trial https://www.techtarget.com/pharmalifesciences/news/366607531/GSK-Launches-Phase-3-Trial-for-5-in-1-Meningitis-Vaccine GSK Launches Phase 3 Trial for 5-in-1 Meningitis Vaccine | TechTarget GSK recently announced that the first patients have been dosed in a Phase 3 clinical trial investigating its 5-in-1 meningitis vaccine candidate, MenABCWY. phase 3 trial5 in 1 https://www.finanznachrichten.de/nachrichten-2026-04/68128572-amgen-phase-3-trial-of-tepezza-meets-primary-and-key-secondary-endpoints-020.htm Amgen: Phase 3 Trial Of TEPEZZA Meets Primary And Key Secondary Endpoints THOUSAND OAKS (dpa-AFX) - Amgen (AMGN) announced positive topline results from a Phase 3 trial of TEPEZZA administered by subcutaneous injection via an on-body... phase 3 trial https://refractor.io/infectious-diseases/moderna-mrna-rsv-vaccine-phase-3-trial-results/ Moderna's mRNA RSV vaccine delivers impressive Phase 3 trial results Sep 20, 2024 - Moderna has announced promising results from its Phase 3 trial testing an mRNA vaccine for RSV in older adults. Data indicates the vaccine is nearly 84%... phase 3 trialrsv vaccinemodernamrna https://www.jnj.com/media-center/press-releases/janssen-announces-start-of-phase-3-trial-for-investigational-respiratory-syncytial-virus-rsv-vaccine-in-older-adults Janssen Announces Start of Phase 3 Trial for Investigational Respiratory Syncytial Virus (RSV)... Jul 17, 2025 - Positive Phase 2b data supporting further evaluation will be presented at IDWeek 2021 phase 3 trial https://investingnews.com/daily/life-science-investing/pharmaceutical-investing/bellerophon-halts-phase-3-trial/ Bellerophon Halts Phase 3 Trial | INN Jan 4, 2026 - The news which no investor looks forward to hearing is that a clinical-stage biopharmaceutical company will halt a Phase 3 clinical study. In this case,... phase 3 trialbellerophonhaltsinn https://www.mskcc.org/news/pivotal-results-phase-3-trial-shows-longer-overall-survival-cabozantinib-placebo-patients-advanced-liver Pivotal Results from Phase 3 Trial Shows Longer Overall Survival with Cabozantinib than with... New researched published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options... phase 3 trial https://finviz.com/news/98855/palvella-therapeutics-completes-enrollment-for-pivotal-phase-3-trial-of-qtorin-rapamycin Palvella Therapeutics Completes Enrollment for Pivotal Phase 3 Trial of QTORIN Rapamycin Stock screener for investors and traders, financial visualizations. phase 3 trial https://investingnews.com/landmark-phase-3-trial-meets-primary-endpoints-in-a-cardiovascular-primary-prevention-study-of-12000-patients/ LANDMARK PHASE 3 TRIAL MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF... Oct 2, 2025 - Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy... phase 3 trial https://www.fiercebiotech.com/biotech/pfizer-pulls-50-people-phase-3-trial-gcp-violations Pfizer pulls 50% of people from phase 3 trial for GCP violations Feb 17, 2023 - Pfizer could still potentially file for approval in 2025, subject to the agreement of regulators to proposed modifications of the clinical trial plan. phase 3 trial https://www.businesswire.com/news/home/20240610964254/en/Arcus-Biosciences-Completes-Patient-Enrollment-in-Phase-3-Trial-Evaluating-a-Domvanalimab-Containing-Regimen-in-First-Line-Metastatic-Upper-GI-Cancers Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a... Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therap... phase 3 trialpatient enrollmentarcusbiosciencescompletes https://www.biospace.com/tioga-pharmaceuticals-begins-phase-3-trial-of-asimadoline-in-irritable-bowel-syndrome Tioga Pharmaceuticals Begins Phase 3 Trial of Asimadoline in Irritable Bowel Syndrome - BioSpace phase 3 trial https://www.prnewswire.com/news-releases/hansa-biopharma-completes-enrolment-in-global-pivotal-phase-3-trial-of-imlifidase-in-anti-glomerular-basement-membrane-disease-302323969.html Hansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in... /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA) today announced it has completed the enrolment of patients in the GOOD-IDES-02 trial, a... phase 3 trialhansa biopharma https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1468279/full Frontiers | A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy,... PurposeThe management of rectal adenocarcinoma has evolved during the last decade, shifting from a conventional neoadjuvant chemoradiotherapy, surgery, and a... phase 3 trial https://www.takeda.com/newsroom/statements/2019/takeda-provides-update-on-tourmaline-al1-phase-3-trial/ Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial in AL Amyloidosis Takeda Provides Update on TOURMALINE-AL1 Phase 3 Trial phase 3 trial https://www.fiercebiotech.com/biotech/merck-moderna-post-phase-3-trial-closely-watched-mrna-cancer-vaccine Merck, Moderna unveil phase 3 trial plan for mRNA cancer vaccine Jul 10, 2023 - Merck has registered a phase 3 trial for Moderna-partnered mRNA cancer vaccine mRNA-4157 in resectable melanoma following positive midstage data. phase 3 trialmerckmodernaunveil https://www.cincinnatichildrens.org/service/c/clinical-trials/studies/AALL1631 AALL1631: International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic... AALL1631: International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two... phase 3 trialphiladelphia chromosomeinternational https://www.amgen.com/newsroom/press-releases/2025/10/landmark-phase-3-trial-vesaliuscv-meets-primary-endpoints-in-a-cardiovascular-primary-prevention-study-of-12000-patients LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION... phase 3 trial https://www.biospace.com/business/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual-meeting-2024 BridgeBio to Present Additional Analyses from the Phase 3 ATTRibute-CM Trial of Acoramidis in... https://www.techtarget.com/pharmalifesciences/news/366607088/Novartis-Cancer-Treatment-Fails-in-Phase-3-Clinical-Trial Novartis Cancer Treatment Fails in Phase 3 Clinical Trial | TechTarget Novartis cancer treatment Kymriah did not meet its primary endpoint of event-free survival compared to treatment with the standard-of-care in the Phase 3... phase 3 clinical trialcancer treatmentnovartisfailstechtarget https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_lilly_announce_positive_top_line_results_from_phase_3_trial_of_tanezumab_for_the_treatment_of_osteoarthritis_oa_pain Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The... Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that a 16-week Phase 3 study in patients with osteoarthritis (OA) pain evaluating... https://www.seattlechildrens.org/research/research-studies-clinical-trials/current-studies/all/aost2031----a-phase-3-randomized-controlled-trial-comparing-open-vs-thoracoscopic-management-of-pulmonary-metastases-in-patients-with-osteosarcoma--study00003789/ AOST2031: A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of... Patients with osteosarcoma typically receive a combination of systemic therapy and surgical control of the primary tumor site. Surgical control of... randomized controlled trial https://refractor.io/infectious-diseases/large-phase-3-hiv-vaccine-trial-fails-nih/ Major setback as another large ongoing Phase 3 HIV vaccine trial fails Sep 20, 2024 - In a blow to researchers across the world, the only HIV vaccine currently in Phase 3 human trials has been deemed a failure. The experimental vaccine's failure... https://www.biospace.com/hansa-announces-first-patient-dosed-with-imlifidase-in-a-global-pivotal-phase-3-trial-in-anti-glomerular-basement-membrane-anti-gbm-disease Hansa announces first patient dosed with imlifidase in a global pivotal phase 3 trial in... May 30, 2023 - Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, announced the first patient has been dosed with imlifidase in the...